Leading specialty therapy drugs U.S. - net price change 2017-2019

Published by
Matej Mikulic,
Jun 17, 2020
This statistic shows select widely-used specialty therapeutic drugs in the United States regarding their net price change between 2017 a d 2019. The best-selling drug worldwide - Humira (adalimumab) - had a net price growth of 16 percent within two years. Price increases of drugs often appear without being based on new clinical evidence and are therefore hotly discussed.

Net price change of leading specialty therapy drugs in the U.S. in 2017-2019

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

October 2019

Region

United States

Survey time period

2017 to 2019

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

6

Other regions

10

Related statistics

10

Further related statistics

9

Further Content: You might find this interesting as well

Statistics

Topics

Drug pricing in the U.S.Global pharmaceutical industryPharmaceutical industry in the U.S.Health expenditures in the U.S.Americans without health insurance
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.
Menu